Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2021-04-07 2021-04-07
Drug Identification Number 00717282 00717282
Brand name PRIMAXIN 500 PRIMAXIN 500
Common or Proper name imipenem and cilastatin sodium for injection imipenem and cilastatin sodium for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients IMIPENEM CILASTATIN IMIPENEM CILASTATIN
Strength(s) 500MG 500MG 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 25 vial 25 vial
ATC code J01DH J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-04-19 2021-04-19
Actual start date
Estimated end date 2021-04-30 2021-04-30
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Company comments
Health Canada comments